Cypherpunk Technologies Inc
leaptx.comWhat Do They Do?
Invests in Zcash and privacy technologies, and develops antibody therapies for cancer through its Leap subsidiary.
10-K for FY2025, filed Mar 16, 2026We are a privacy technology company implementing a digital asset treasury strategy anchored by Zcash and, through our subsidiary Leap, are…View ↗
We are not a typical digital asset treasury company. While we hold digital assets as part of our strategy, our core business is…View ↗
Our subsidiary, Leap, is a biopharmaceutical company developing novel biomarker-targeted antibody therapies designed to treat patients with…View ↗
How Are They Changing?
- Net income
-
Sources
10-Q for Q2 FY2026, filed Aug 12, 2026
$39.4MView ↗
- ▲ Now profitable
- vs −$16.6M in Q2 FY2025
-
Sep 2, 2026
Regained compliance with Nasdaq’s minimum bid price rule
Sources
8-K, filed Sep 2, 2026
On September 2, 2026, the Company received a letter from Nasdaq notifying the Company that it had regained compliance with Nasdaq Listing…View ↗
-
Aug 18, 2026
Acquired a Zcash mining fleet and related hosting agreements
The purchase added mining equipment and hosting agreements, expanding the business beyond its ZEC treasury and privacy investments.
Sources
8-K, filed Aug 18, 2026
Pursuant to the APA, the Buyer agreed (i) to purchase and acquire from the Seller certain assets and rights (collectively, the “Purchased…View ↗
-
Jul 21, 2026
Received Nasdaq notice of a minimum bid price deficiency
The notice did not affect the listing or trading of its shares.
Sources
8-K, filed Jul 21, 2026
On July 20, 2026, Cypherpunk Technologies Inc. (the “Company”) received a notification letter (the “Closing Bid Price Deficiency Letter”)…View ↗
A new privacy and treasury focus
The earlier report described a biopharmaceutical developer focused on cancer antibody therapies. The latest report adds a privacy-technology strategy centered on accumulating Zcash and investing in privacy technologies, while continuing cancer drug development through Leap.
10-K for FY2022, filed Mar 24, 2023 10-K for FY2025, filed Mar 16, 2026We are a biopharmaceutical company developing novel biomarker-targeted antibody therapies designed to treat patients with cancer by…View ↗
We are a privacy technology company implementing a digital asset treasury strategy anchored by Zcash and, through our subsidiary Leap, are…View ↗
We are not a typical digital asset treasury company. While we hold digital assets as part of our strategy, our core business is…View ↗
On November 12, 2025, we changed our name from “Leap Therapeutics, Inc.” to “Cypherpunk Technologies Inc.” and changed our trading symbol…View ↗
Who Do They Compete With?
Competes with Strategy and a16z crypto
10-K for FY2025, filed Mar 16, 2026The privacy technology, cryptocurrency, and digital asset treasury industries are characterized by continuing technological advancement and…View ↗
Loading...
